Clarissa Desjardins's most recent trade in Insmed Inc was a trade of 5,058 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 67,007 (0%) | 0% | - | Common Stock | |
Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 61,949 (0%) | 0% | - | Common Stock | |
Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 48,787 (0%) | 0% | - | Common Stock | |
Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 35,595 (0%) | 0% | - | Common Stock | |
Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 20,950 (0%) | 0% | - | Common Stock | |
Xenon Pharmaceuticals Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |